Fluor Guides Q4 Adj. EPS Well Above Estimates - Update

By RTTNews Staff Writer ✉ | Published: 11/4/2022 7:02 AM ET

While reporting financial results for the third quarter on Friday, engineering company Fluor Corp. (FLR) provided its adjusted earnings guidance for the fourth quarter in a range of $0.50 to $0.60 per share.

On average, four analysts polled by Thomson Reuters expect the company to report earnings of $0.42 per share for the quarter. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Editors Pick

Children's Robes, Pajamas Recalled On Burn Risks

The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ...

Cigna Q4 Results Top View; Sees Higher FY23 Earnings, But Below Market

Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view.

Sanofi Q4 Profit Climbs, Sees Slower Earnings Growth In FY23; Stock Down

French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...